Variable | No. of cases | Glutamine (μM) | P values | |
---|---|---|---|---|
Mean | SD | |||
Age (year) | 0.147 | |||
≥ 65 | 56 | 593.52 | 418.88 | |
< 65 | 65 | 493.14 | 337.12 | |
Sex | 0.860 | |||
Male | 73 | 534.65 | 344.40 | |
Female | 48 | 547.11 | 429.81 | |
BMI | 0.278 | |||
< 18.5 | 12 | 383.02 | 343.87 | |
18.5–23.9 | 64 | 577.94 | 394.39 | |
24–26.9 | 28 | 480.44 | 378.68 | |
≥ 27 | 17 | 603.22 | 326.02 | |
Tumor size (cm) | 0.503 | |||
≥ 5 | 68 | 519.12 | 373.75 | |
< 5 | 53 | 565.87 | 387.38 | |
Tumor location | 0.161 | |||
Colon | 61 | 491.58 | 349.99 | |
Rectum | 60 | 588.41 | 403.25 | |
Tumor differentiation | 0.563 | |||
Well and moderate | 93 | 550.60 | 376.72 | |
Poor | 28 | 503.05 | 390.74 | |
Depth of invasion | 0.007* | |||
Tis–T2 | 23 | 601.45 | 360.58 | |
T3 | 82 | 575.39 | 387.13 | |
T4 | 16 | 267.23 | 237.72 | |
Lymph node metastasis | 0.037* | |||
Yes | 59 | 466.17 | 409.97 | |
No | 62 | 609.47 | 335.31 | |
Venous permeation | 0.161 | |||
Yes | 55 | 486.62 | 416.73 | |
No | 66 | 583.75 | 341.18 | |
Perineural invasion | 0.94 | |||
Yes | 27 | 534.73 | 362.30 | |
No | 94 | 540.99 | 385.40 | |
CEA | ||||
High | 21 | 435.13 | 309.45 | 0.017* |
Normal | 60 | 636.65 | 329.39 | |
Survival status | 0.259 | |||
Death | 42 | 486.07 | 427.31 | |
Survival | 79 | 568.05 | 350.03 | |
Metastasis/recurrence | 0.008* | |||
Yes | 49 | 430.11 | 372.35 | |
No | 72 | 614.11 | 367.43 |